Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Industry,Science & Environment
November 5, 2026
Researchers have identified that an aqueous extract from the herb Phyllanthus urinaria (PU) may help prevent acute kidney injury caused by the chemotherapy drug cisplatin. In a study using mouse models, the treatment helped maintain healthy kidney function and preserved tissue structure.
The extract appears to function by reducing oxidative stress and inflammation while managing protein pathways associated with programmed cell death. Findings suggest the intervention helps restore antioxidant defenses in renal cells exposed to toxic chemotherapy side effects.
While initial results in animal models are encouraging, the research team emphasizes that this is a preclinical study. Further investigation is required to identify the active compounds and determine safety for human application.
Cisplatin is a highly effective chemotherapy treatment, but it is notorious for causing kidney toxicity in nearly 30% of patients. Because effective preventive medications remain scarce, the medical community frequently relies on supportive care and renal replacement therapies to manage drug-induced injuries.
The search for natural, protective agents has become a focal point in pharmacology as clinicians seek ways to reduce treatment interruptions. This study aligns with a broader trend of investigating plant-based extracts to improve the tolerability of standard cancer treatments without compromising their efficacy.